rxstat › Shortages › Methotrimeprazine
Methotrimeprazine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Methotrimeprazine products are in shortage in Canada (1 of 4 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 17, 2026.
In shortage since
Jun 9, 2026
Est. full return
Jul 17, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMETHOPRAZINE
5MG · TABLET · AA PHARMA INC
DIN 02238404 · since Jun 9, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
ResolvedMETHOPRAZINE
5MG · TABLET · AA PHARMA INC
DIN 02238404 · ended Mar 11, 2025 · Disruption of the manufacture of the drug.
ResolvedMETHOPRAZINE
25MG · TABLET · AA PHARMA INC
DIN 02238405 · ended Dec 18, 2024 · Disruption of the manufacture of the drug.
ResolvedNOZINAN
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Sep 29, 2023 · Other (Please describe in comments)
ResolvedNOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended May 13, 2022 · Other (Please describe in comments)
ResolvedMETHOPRAZINE
5MG · TABLET · AA PHARMA INC
DIN 02238404 · ended Mar 15, 2023 · Disruption of the manufacture of the drug.
ResolvedMETHOPRAZINE
2MG · TABLET · AA PHARMA INC
DIN 02238403 · ended Mar 15, 2023 · Disruption of the manufacture of the drug.
ResolvedNOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Dec 15, 2022 · Other (Please describe in comments)
ResolvedMETHOPRAZINE
25MG · TABLET · AA PHARMA INC
DIN 02238405 · ended Aug 31, 2021 · Disruption of the manufacture of the drug.
AvoidedNOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Aug 7, 2020 · Other (Please describe in comments)
ResolvedNOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended May 4, 2020 · Other (Please describe in comments)
ResolvedNOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Feb 20, 2019 · Other (Please describe in comments)
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
Methotrimeprazine is currently affected by an active shortage report filed with Health Canada by AA PHARMA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Methotrimeprazine is classified under “ANTIPSYCHOTICS” (ATC N05AA).
Recent changes
Common questions
When will Methotrimeprazine be back in stock in Canada?
The latest manufacturer estimate is Jul 17, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Methotrimeprazine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.